(b).
Prognostic parameters | EGFR | P value | CK5/6 | P value | ||
---|---|---|---|---|---|---|
Tumour stage | ||||||
Stage I | 5 | 0 | >0.05 | 2 | 3 | >0.05 |
Stage II | 12 | 4 | 11 | 5 | ||
Stage III | 12 | 1 | 7 | 6 | ||
Stage IV | 2 | 0 | 2 | 0 | ||
| ||||||
Margins | ||||||
Infiltrative | 22 | 3 | >0.05 | 13 | 12 | >0.05 |
Pushing margin | 9 | 2 | 9 | 2 | ||
| ||||||
Necrosis | ||||||
Present | 12 | 4 | >0.05 | 11 | 5 | >0.05 |
Absent | 19 | 1 | 11 | 9 | ||
| ||||||
Infiltrate | ||||||
Present | 20 | 3 | >0.05 | 15 | 8 | >0.05 |
Absent | 11 | 2 | 7 | 6 | ||
| ||||||
Lymph node metasatases | ||||||
Absent | 11 | 1 | >0.05 | 6 | 6 | >0.05 |
1 to 3 | 11 | 3 | 11 | 3 | ||
>4 | 9 | 1 | 5 | 5 | ||
| ||||||
Ki-67 | ||||||
Positive | 25 | 4 | >0.05 | 16 | 13 | >0.05 |
Negative | 6 | 1 | 6 | 1 |